Does oxidative stress participate in nerve cell death in Parkinson's disease?
- PMID: 8375433
- DOI: 10.1159/000118538
Does oxidative stress participate in nerve cell death in Parkinson's disease?
Abstract
Parkinson's disease is characterized by a massive neuronal loss in several cell groups of the midbrain. However, the most consistent lesions are observed in dopaminergic systems including nigral neurons. Although the cause of this neuronal loss remains unknown, oxidative stress has been suspected to participate in the mechanism of nerve cell death for several reasons. (1) Lipid peroxidation, a consequence of oxygen free radical production, has been found to be elevated in the substantia nigra in Parkinson's disease. (2) Catecholaminergic neurons containing neuromelanin, an autooxidation by-product of catecholamines, are more vulnerable in Parkinson's disease than non-melanized catecholaminergic neurons. (3) Catecholaminergic neurons surrounded by a low density of cells containing glutathione peroxidase, a free radical scavenging enzyme, are more susceptible to degeneration in Parkinson's disease than those well protected against oxidative stress. (4) The content of iron, a compound which exacerbates the production of free radicals in catecholaminergic neurons, is increased in the substantia nigra in Parkinson's disease. It remains, however, to be determined whether oxidative stress participates to the cause of the disease or only represents a consequence of nerve cell death.
Similar articles
-
Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?Ann Neurol. 1992;32 Suppl:S88-93. doi: 10.1002/ana.410320715. Ann Neurol. 1992. PMID: 1510386 Review.
-
The possible role of iron in the etiopathology of Parkinson's disease.Mov Disord. 1993;8(1):1-12. doi: 10.1002/mds.870080102. Mov Disord. 1993. PMID: 8419792 Review.
-
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.Acta Neurol Scand Suppl. 1993;146:6-13. Acta Neurol Scand Suppl. 1993. PMID: 8333254 Review.
-
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?Neuroscience. 1996 Aug;73(4):979-87. doi: 10.1016/0306-4522(96)00100-5. Neuroscience. 1996. PMID: 8809817
-
Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective.Clin Neurol Neurosurg. 1992;94 Suppl:S9-11. doi: 10.1016/0303-8467(92)90008-q. Clin Neurol Neurosurg. 1992. PMID: 1320533 Review.
Cited by
-
Cx43 Mediates Resistance against MPP⁺-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells via Modulating the Mitochondrial Apoptosis Pathway.Int J Mol Sci. 2016 Nov 1;17(11):1819. doi: 10.3390/ijms17111819. Int J Mol Sci. 2016. PMID: 27809287 Free PMC article.
-
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.Neurobiol Aging. 2017 Jun;54:175-186. doi: 10.1016/j.neurobiolaging.2017.03.007. Epub 2017 Mar 16. Neurobiol Aging. 2017. PMID: 28390825 Free PMC article.
-
Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.Drugs Aging. 2012 Feb 1;29(2):81-91. doi: 10.2165/11597550-000000000-00000. Drugs Aging. 2012. PMID: 22233455 Review.
-
Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies.Am J Pathol. 2002 Sep;161(3):885-94. doi: 10.1016/S0002-9440(10)64249-6. Am J Pathol. 2002. PMID: 12213717 Free PMC article.
-
Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.Neurochem Res. 2011 Nov;36(11):1991-2001. doi: 10.1007/s11064-011-0523-1. Epub 2011 Jun 18. Neurochem Res. 2011. PMID: 21688047
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical